Researchers conducted a systematic literature review to identify randomized controlled trials comparing 8 different types of foot orthotics.
The use of non-opioid analgesic therapies is increasing among ED physicians.
Investigators sought to determine whether phrenic nerve infiltration and suprascapular nerve block would control acute ipsilateral shoulder pain after thoracotomy.
The FDA has approved Apadaz for the short-term management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
The most promising tools to predict acute pain after cesarean delivery are local anesthetic infiltration before placement of spinal anesthesia, and asking patients simple questions about anticipated pain and analgesic needs.
Preliminary results suggest that a new sublingual buprenorphine wafer may offer high bioavailability and fast absorption for patients treated for acute and chronic pain.
Acute pain management in the emergency department with low-dose ketamine may provide pain relief comparable with morphine at 30 minutes.
ACTTION Consensus Provides Best Practices for the Design of Pediatric Clinical Trials Focused on Acute PainJanuary 08, 2018
Key factors susceptible to improve the design of clinical trials on analgesics for acute pain in pediatric populations were reviewed and recommendations published.
The most common work-related musculoskeletal disorders in physicians were found to be degenerative cervical spine disease, rotator cuff pathology, degenerative lumbar spine disease, and carpal tunnel syndrome.
Compared to other commonly used opioids, buprenorphine offers a ceiling effect for respiratory depression and less abuse potential, less cognitive impairment, and less constipation.
Nonopioid Analgesic Combination and Opioid Combinations Provide Similar Analgesic Effects for Acute Extremity PainDecember 04, 2017
Nonopioid analgesic combinations may be noninferior to opioid/acetaminophen combinations for reducing acute extremity pain.
Trevena has submitted their New Drug Application to the FDA for Olinvo, an oliceridine injection, for the management of moderate-to-severe pain in the hospital and similar settings.
Opioid treatment of acute postoperative pain was shown to cause high rates of postoperative nausea and vomiting, particularly in women and younger patients.
SoluMatrix indomethacin may represent a treatment option for the management of moderate acute pain, including patients in emergency room settings.
Information on fever-reducing medications including formulation, strength and dosage.
A number of shortcomings are associated with systematic reviews and meta-analyses of postoperative care.
There was a correlation for consistent vitamin D supplementation with increase in physical component of the SF-12 score.
An online tool predicts which patients with chest pain are likely to have normal non-invasive test results and remain free of cardiac adverse events.
Intravenous lidocaine seems safe for reducing pain among patients in the intensive care unit with varying degrees of organ dysfunction.
Opioids prescribed for pain following a motor vehicle collision do not reduce the likelihood of developing persistent pain.
A new evidence-based classification system for chronic sickle cell disease pain was recently published.
In a comparative study, topical liposomal lidocaine proved most effective for analgesia during infant vaccination.
Many patients experience pain months after nephrectomy. Continuous surgical site analgesia may offer the best long-term pain control.
Psychological factors may influence the severity and duration of pain following surgery.
YHS presents a potential new treatment option for neuropathic pain management, without the tolerance observed with many analgesic drugs.
The researchers concluded that the results from this systematic review and meta-analysis are promising, and that it is worth investing in these recommendations in future research to be able to eventually offer massage therapy to surgical patients experiencing pain.
Nebulized fentanyl is as effective as IV opioids for the treatment of acute pain.
Researchers hypothesize that communicating opioid addiction risks to patients using real-life narratives could be effective and low-cost.
Pain management questions from patient satisfaction surveys have been used to influence Medicare reimbursement rates and have resulted in unintended consequences in light of the nation's opioid epidemic.
In states where marijuana is legalized for medicinal purposes, Medicare's prescription drug benefit program has lowered its spending due to reduced prescription drug use.
Clinical Pain Advisor Articles
- Low Back Pain: Contributing Factors, Prophylactic Strategies, and Effective Treatments
- Betel Quid Addiction and Implications for Substance Use Disorder
- Peripherally Acting Opioid and Cannabinoid May Be Effective for Neuropathic Pain
- New Blood Test Shows High Accuracy for Diagnosing Fibromyalgia
- Positive Affect, Resilience, and Pain in MS With Chronic Pain
- Exploring the Connections Between Neuropathic Pain and Comorbid Mood Disorders
- Medical Marijuana Laws, Dispensaries May Reduce Deaths From Opioid Overdose
- Ketamine Infusion May Be Effective for the Short-Term Relief of CRPS-Associated Pain
- An Avenue for the Development of Opioid Adjuncts for Enhanced Analgesia, Reduced Abuse Potential
- Non-Opioid Therapies for Pain Management in the ED
- Opioids vs Nonopioid Medications for Chronic Back, Knee, and Hip Osteoarthritis Pain
- Conventional vs High-Frequency Spinal Cord Stimulation for Chronic Pain
- Evaluating Headache in the Elderly: Primary vs Secondary Causes
- Custom Foot Orthotics vs OTC Insoles for Plantar Heel Pain
- Once-Monthly Erenumab Injections May Be Effective for Episodic Migraine Prophylaxis